RhAPPcast

Rheumatology Advanced Practice Providers (RhAPP)
  • 5,0 (3)
  • МЕДИЦИНА
RhAPPcast

This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).    Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 

  1. FAQ: How do you interpret radiographic progression using modified-vdHS or mTSS

    -3 ДН.

    FAQ: How do you interpret radiographic progression using modified-vdHS or mTSS

    Join Kyle George as he explains the use of radiographic scoring systems in assessing structural damage and progression in psoriatic arthritis (PsA). In this informative video, Kyle discusses the modified Van der Heijde Sharp score (mVHS) and the modified Total Sharp score (mTSS), both of which utilize radiographic images to document changes in the hands, wrists, and feet.

    2 мин.
  2. Med. Review Video Module: What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?

    16.12.2024

    Med. Review Video Module: What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?

    Join Jessica Farrell, PharmD, a clinical pharmacist and board member of RhAPP, as she breaks down the efficacy of ixekizumab across the GRAPPA domains. In this video, she covers the impact of ixekizumab on peripheral arthritis, axial disease, enthesitis, dactylitis, skin, and nail psoriasis, based on the latest clinical trial data. Learn how this treatment can significantly improve various symptoms in patients with psoriatic arthritis.

    7 мин.
  3. Medication Review Video Module: What is the safety profile of guselkumab in PsO and PsA?

    11.12.2024

    Medication Review Video Module: What is the safety profile of guselkumab in PsO and PsA?

    Join Cassie Dolecki, a clinical pharmacy specialist in Rheumatology at Allegheny Health Network in Pittsburgh, Pennsylvania, as she discusses the safety profile of guselkumab in treating psoriatic arthritis and psoriasis. Cassie highlights findings from the DISCOVER-2 trial, a phase three study that assessed the efficacy and safety of guselkumab compared to placebo in biologic-naive patients with active psoriatic disease over two years.

    2 мин.
  4. FAQ: How does axial PsA differ from AS clinically, genetically, and radiographically

    04.12.2024

    FAQ: How does axial PsA differ from AS clinically, genetically, and radiographically

    Join Kyle George, a physician assistant and member of RhAPP, as he explores the clinical, genetic, and radiographic differences between axial psoriatic arthritis (Axial PsA) and ankylosing spondylitis (AS). In this FAQ session, Kyle provides insights into how these conditions, despite both causing inflammatory spine pain, differ significantly in their presentation and underlying mechanisms.

    3 мин.

  5. 20.11.2024

    Journal Club Video Module

    Join Jessica Farrell, a clinical pharmacist at Albany Medical Center's Division of Rheumatology and faculty member at Albany College of Pharmacy and Health Sciences, as she discusses a significant study published in "Rheumatology and Therapy" in August 2023 by Dr. Miscol. The study titled "Six-Month Persistence and Multi-Domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis" presents real-world data from the CorEvitas PsA and SpA registry.

    4 мин.
  6. RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk

    13.11.2024

    RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk

    In this episode of RhAPPcast, host Amanda Mixon, PA-C, dives into the complexities of IL-17 inhibitors and their association with inflammatory bowel disease (IBD). Joined by Candace Ryan, a seasoned rheumatology expert, they explore the benefits and risks of IL-17 therapy for rheumatic patients. Tune in to gain insights into current evidence, clinical trials, and best practices for managing these therapies

    31 мин.

  7. 06.11.2024

    FAQ: Why is Binding CD64+ Important When Discussing IL23 Directed Therapy

    Join Heather Mambretti, and a member of RhAPP, as she discusses the significance of CD64 positive binding in IL-23 directed therapy. In this video, Heather explains how targeting CD64 positive cells enhances the specificity and efficacy of IL-23 directed treatments, such as guselkumab, by delivering therapeutic agents directly to sites of inflammation.

    4 мин.

  8. 04.11.2024

    Journal Club Review Video Module

    Ingrid Pan, PharmD, pediatric clinical pharmacist at Children's Hospital Colorado, reviews an interim analysis of a Phase 1 trial on the safety and efficacy of upadacitinib in pediatric patients with polyarticular-course juvenile idiopathic arthritis (pcJIA). The study, published in Annals of the Rheumatic Diseases, shows promising results, with ACR 30, 50, and 70 response rates at week 12, and significant improvements in disease activity. Ingrid highlights the low rate of serious adverse eve...

    7 мин.
См. все (59)

Оценки и отзывы

5
из 5
Оценок: 3

Об этом подкасте

This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).    Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 

Информация

  • Автор
    Rheumatology Advanced Practice Providers (RhAPP)
  • Годы выхода
    2023 - 2025
  • Выпуски
    59
  • Ограничения
    Без ненормативной лексики
  • Авторские права
    © 2025 RhAPPcast
  • Сайт подкаста
    RhAPPcast

Вам может также понравиться

Чтобы прослушивать выпуски с ненормативным контентом, войдите в систему.

Следите за новостями подкаста

Войдите в систему или зарегистрируйтесь, чтобы следить за подкастами, сохранять выпуски и получать последние обновления.
Выберите страну или регион

Африка, Ближний Восток и Индия

Азиатско-Тихоокеанский регион

Европа

Латинская Америка и страны Карибского бассейна

США и Канада